Page last updated: 2024-09-02
2,3-bis(3'-hydroxybenzyl)butyrolactone and Bone Loss, Perimenopausal
2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Bone Loss, Perimenopausal in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Brüggemann-Rotgans, IE; Kardinaal, AF; Morton, MS; van Beresteijn, EC | 1 |
Other Studies
1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Bone Loss, Perimenopausal
Article | Year |
---|---|
Phyto-oestrogen excretion and rate of bone loss in postmenopausal women.
Topics: 4-Butyrolactone; Aging; Bone Density; Chromans; Equol; Estrogens, Non-Steroidal; Female; Gas Chromatography-Mass Spectrometry; Genistein; Humans; Isoflavones; Lignans; Linear Models; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Postmenopause; Prospective Studies; Time Factors | 1998 |